Im having trouble understanding the results of the breast test ,is the test results just for stage 4 and the Iiq test is 10% better ? Or is iiiq sensitivity 69%and specificity 78% across all stages ? I’m finding it difficult to work out . In the announcement it states Roche’s early stage percentages but not ours and if iiq 69/78 % is across early stage then surely Iiq test is far superior and more than 10% better ? can anyone explain this please
Ann: Positive results for SubB2M Breast Cancer Test, page-34
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.010(2.22%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 44.0¢ | 43.0¢ | $7.597K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21334 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 8500 | 1 |
View Market Depth
| Last trade - 12.25pm 13/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |